{
  "id": "5343fc1aaeec6fbd07000003",
  "type": "factoid",
  "question": "Which is the gene mutated in type 1 neurofibromatosis?",
  "ideal_answer": "NF1 gene, encoding neurofibromin 1",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/16741618",
    "http://www.ncbi.nlm.nih.gov/pubmed/10712197",
    "http://www.ncbi.nlm.nih.gov/pubmed/9326316",
    "http://www.ncbi.nlm.nih.gov/pubmed/8528106",
    "http://www.ncbi.nlm.nih.gov/pubmed/8699317",
    "http://www.ncbi.nlm.nih.gov/pubmed/9190537",
    "http://www.ncbi.nlm.nih.gov/pubmed/17573495",
    "http://www.ncbi.nlm.nih.gov/pubmed/17209131",
    "http://www.ncbi.nlm.nih.gov/pubmed/20442305",
    "http://www.ncbi.nlm.nih.gov/pubmed/10973261",
    "http://www.ncbi.nlm.nih.gov/pubmed/16861979",
    "http://www.ncbi.nlm.nih.gov/pubmed/8845843",
    "http://www.ncbi.nlm.nih.gov/pubmed/11257108",
    "http://www.ncbi.nlm.nih.gov/pubmed/10874316",
    "http://www.ncbi.nlm.nih.gov/pubmed/23578956",
    "http://www.ncbi.nlm.nih.gov/pubmed/7485153",
    "http://www.ncbi.nlm.nih.gov/pubmed/9668168",
    "http://www.ncbi.nlm.nih.gov/pubmed/12695655",
    "http://www.ncbi.nlm.nih.gov/pubmed/18196300",
    "http://www.ncbi.nlm.nih.gov/pubmed/17564507",
    "http://www.ncbi.nlm.nih.gov/pubmed/15770836",
    "http://www.ncbi.nlm.nih.gov/pubmed/17019046",
    "http://www.ncbi.nlm.nih.gov/pubmed/8264648",
    "http://www.ncbi.nlm.nih.gov/pubmed/17295913",
    "http://www.ncbi.nlm.nih.gov/pubmed/21354044"
  ],
  "snippets": [
    {
      "text": "Individuals with NF1 harbor 1 mutated NF1 allele",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23578956",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "type 1 (NF1) is a hereditary disorder caused by mutations in the NF1 gene",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354044",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The NF1 gene, mutated in NF1, is also commonly mutated in sporadic glioblastoma multiforme (GBM)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20442305",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18196300",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Neurofibromatosis type 1 (NF1) is a common disorder of dysregulated tissue growth secondary to mutations in the tumor suppressor gene NF1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17573495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "tumor suppressor protein neurofibromin, which is mutated in NF1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17564507",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecting about 1:3,500 individuals. NF1 exon 7 displays weakly defined exon-intron boundaries",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17295913",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Loss of heterozygosity (LOH) of NF1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17209131",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder resulting in the growth of a variety of tumours, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17209131",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ten occur in both children and adults as sporadic events with no family history of the disease, but they are also among the clinical manifestations of a significant number of familial cancer syndromes, including familial retinoblastoma, neurofibromatosis 1 and 2, tuberous sclerosis, and Cowden, Turcot, Li-Fraumeni and nevoid basal cell carcinoma (Gorlin) syndromes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17019046",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These genes include RB1, NF1, NF2, TSC1, TSC2, TP53, PTEN, APC, hMLH1, hPSM2, and PTCH",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17019046",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "von Recklinghausen syndrome (NF-1) (OMIM 162200) carrying NF1 germline mutations",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16861979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "mutations of the NF1 gene have been reported in patients with neurofibromatosis type 1 (NF1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16741618",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16741618",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Neurofibromatosis 1 gene (NF1 ) fulfills the criteria of a tumor suppressor gene and is deleted or mutated heterozygously in patients with NF1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770836",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "type 1 (NF1) is one of the most common human genetic disorders and is associated with significant morbidity and mortality. The gene responsible for this disorder, NF1, encodes neurofibromin,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12695655",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " genes mutated in these two disorders encode tumor suppressor proteins, termed neurofibromin (NF1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257108",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " tumour-suppressor genes, Nf1 and Trp53. Humans with mutations in NF1 develop neurofibromatosis type I (NF1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10973261",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "type 1 (NF1) is an autosomal dominant genetic disorder affecting one in 3,500 individuals. The mutation rate in the NF1 gene is one of the highest known for human genes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10874316",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10712197",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It is caused by a wide spectrum of mutations affecting the NF1 gene. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9668168",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NF1) is a common familial tumour syndrome with multiple clinical features such as neurofibromas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9668168",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This neoplastic lesion is a common feature of neurofibromatosis type 1 (NF1), one of the most common autosomal dominant disorders. The NF1 gene codes for a protein called \"neurofibromin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9326316",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "type 1 (NF1) and type 2 (NF2) are connected with genes localized on chromosomes 17 and 22, respectively. The genes that are inactivated in neurofibromatosis code for the proteins neurofibromine and merline",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9190537",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "neurofibromatosis type 1 (NF1) gene, well recognized for its high frequency of spontaneous mutations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8845843",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "An NF1 gene was identified as a gene whose loss of function causes an onset of human disorder, neurofibromatosis type I.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8699317",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "type 1 (NF1) is caused by deletions, insertions, translocations, and point mutations in the NF1 gene",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7485153",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "type 1 (NF1) gene is a tumor suppressor gene, and the NF1 gene product, neurofibromin",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8528106",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8264648",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D025542",
    "http://www.uniprot.org/uniprot/NF1_RAT",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016514",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009456",
    "http://www.uniprot.org/uniprot/NF1_HUMAN",
    "http://www.uniprot.org/uniprot/NF1_CHICK",
    "http://www.disease-ontology.org/api/metadata/DOID:8712",
    "http://www.uniprot.org/uniprot/NF1_MOUSE"
  ],
  "exact_answer": "NF1"
}